New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
Gaia FanellaClaudio BaiataElisa CandeloroGianpaolo ToscanoSilvia ColnaghiMarco MauriLucia Princiotta CariddiValentina RebecchiFrancesca SolazzoPaola BanfiMarialuisa PiattiCarlo FerrareseMaurizio VersinoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
MG is a rare disease; clinicians should be aware of possible new-onset MG after SARS-CoV-2 vaccination, especially with the current recommendation of booster doses. The hyperstimulation of the innate immune system or the exacerbation of a subclinical pre-existing MG could be possible explanations.